# Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy

> **NCT03339336** · PHASE2 · TERMINATED · sponsor: **Biogen** · enrollment: 265 (actual)

## Conditions studied

- Small Fiber Neuropathy
- Diabetes Mellitus

## Interventions

- **DRUG:** BIIB074
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03339336
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-31
- **Primary completion:** 2021-04-12
- **Final completion:** 2021-04-12
- **Target enrollment:** 265 (ACTUAL)
- **Why stopped:** Sponsor decision to close study early; not due to safety concerns
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339336, "Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03339336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*